Save time and money with
Med Tech Market
Research
MedTech Business intelligence
supplied by GlobalData
The top 10 orthopedic device companies: financial performance, research activities, and growth strategies
We no longer supply this report
The orthopedic device industry is highly competitive and has reached maturity, as demonstrated by its single digit growth rate. The industry is driven largely by incremental innovation and breakthrough product launches have stalled. Several product lines are also facing severe commoditization due to increased competition. Despite such high levels of competition, the top 15 companies accounted for 95% of the market in 2009. The largest device segments are spinal, knee, and hip implants. The fastest growing segment is orthobiologics.
The report provides detailed profiles of the top 10 orthopedic device companies and brief profiles of five other major players. It elucidates trends associated with companies that develop, manufacture, and market orthopedic devices. Detailed profiles contain descriptions of products, financial performance, and growth strategies together with SWOT analyses. For each company analysis is based on:
- Each company's consolidated and segmental financial performance;
- Each company's growth strategies and major acquisitions and divestments relating to the CV devices market;
- Key partnerships and alliances formed by these companies; and
- Business-related strengths and weaknesses of these companies, and insights into the opportunities and threats facing them.
Key drivers and resistors to growth of leading CV device companies.
Drivers
- Demographics - aging population;
- Preference for biologic implants increasing;
- Growth in emerging markets;
- Physician preferences boosted by CME programs; and
- Continued innovation.
Resistors
- Increasing pricing pressure from buyers and payers;
- Rising usage of comparative efficacy and health economics data;
- Regulatory demand for postmarketing surveillance;
- Review of the PMN pathway in the US; and
- Medical device excise tax amounting to $20bn over the next 20 years
Key benefits of reading this report
- Learn from the business operation strategies of the premier orthopedic device companies to target future growth markets effectively, avoid their mistakes, and replicate their successes.
- Benchmark your performance against the leading orthopedic device companies.
- Analyze the growth strategies of major players in the orthopedic industry and learn how their business models are planned for the next 3 to 5 years.
- Compare performances of the top10 companies in the orthopedic market with respect to acquisitions, new product innovation, geography expansion, and industry challenges.
- Save time, money, and resources on analyzing the performance of leading orthopedic device companies using this report.
Key questions answered by this report
- What was the market value of the global orthopedic device industry in 2009?
- What are the global market values for the major orthopedic device segments?
- What are the key trends observed in the orthopedic device companies and what are the strategic responses that are taking shape?
- Who are the major players in the global orthopedic device market?
- What are the growth strategies of the leading orthopedic device companies?
- What are the strengths, weaknesses, opportunities and threats faced by the top 10 players?
Title Index:
Chapter 1 Introduction
- What is this report about?
- Methodology
Chapter 2 Industry overview
- Summary
- Introduction
- Market segmentation
- Competitive landscape
- Key drivers and resistors
- Key events and trends
- Changes in the PMN pathway will increase regulatory burden
- CME platforms will continue to drive growth despite the Department of Justice (DOJ) clampdown
- CME and inducements
- DOJ settlement with device manufacturers
- Physician Sunshine Act may stifle innovation in the orthopedic device industry
- Impact of decline in hospital capital expenditure on orthopedics minimal in the near term
- Medical device industry bracing for the comparative effectiveness research (CER) era
- Medical device excise tax will influence orthopedic market top line
- Rising regulatory pressure on spinal device makers
Chapter 3 Stryker
- Summary
- Company overview
- Marketed products
- Orthopedic implants
- MedSurg equipment
- Financial performance
- Orthopedic implants
- Hip implant systems
- Knee implant systems
- Trauma implant systems
- Spinal implant systems
- Craniomaxillofacial implant systems
- MedSurg equipments
- Surgical equipment and surgical navigation systems
- Endoscopic and communications systems
- Research and innovation
- Growth strategy
- SWOT
Chapter 4 DePuy
- Summary
- Company overview
- Marketed products
- DePuy Orthopedics
- DePuy Spine
- DePuy Mitek
- Codman & Shurtleff
- Financial performance
- Research and product launches
- Growth strategy
- SWOT
Chapter 5 Zimmer
- Summary
- Company overview
- Marketed products
- Reconstructive
- Dental
- Trauma
- Spine
- OSP
- Financial performance
- Reconstructive
- Knee
- Hip
- Extremities
- Dental
- Trauma
- Spine
- OSP
- Research and innovation
- Growth strategy
- SWOT
Chapter 6 Medtronic
- Summary
- Company overview
- Marketed products
- Financial performance
- Core spinal
- Biologics
- Research and innovation
- Growth strategy
- SWOT
Chapter 7 Synthes
- Summary
- Company overview
- Marketed products
- Trauma
- Spine
- CMF
- Financial performance
- Research and innovation
- Growth strategy
- SWOT
Chapter 8 Smith & Nephew
- Summary
- Company overview
- Marketed products
- Orthopedics
- Endoscopy
- Financial performance
- Orthopedics
- Endoscopy
- Research and innovation
- Growth strategy
- SWOT
Chapter 9 Biomet
- Summary
- Company overview
- Marketed products
- Reconstructive products
- Fixation devices
- Spinal products
- Other
- Financial performance
- Research and innovation
- Growth strategy
- SWOT
Chapter 10 Orthofix
- Summary
- Company overview
- Marketed products
- Spinal products
- Orthopedic products
- Sports medicine
- Financial performance
- Spine
- Orthopedics
- Sports medicine
- Research and innovation
- Growth strategies
- SWOT
Chapter 11 Wright Medical Group
- Summary
- Company overview
- Marketed products
- Hip products
- Knee products
- Extremity products
- Biologics products
- Financial performance
- Hip products
- Knee products
- Extremity products
- Biologic products
- Research and innovation
- Growth strategy
- SWOT
Chapter 12 Conmed
- Summary
- Company overview
- Marketed products
- Arthroscopy
- Powered surgical instruments
- Fnancial performance
- Arthroscopy
- Powered surgical equipments
- Research and innovation
- Growth strategy
- SWOT
Chapter 13 Other major companies
- NuVasive
- Integra LifeSciences
- Arthrocare
- Exactech
- RTI Biologics
- Appendix
- Abbreviations
Pricing:
Electronic (Single User) : EUR 2,812
Hard Copy : EUR 2,885
Electronic (Enterprisewide) : EUR 10,545